Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A

Lupus

Volumn 23, Issue 1, 2014, Pages 69-74

  Zavada J ^a   Pešičková, S Sinikka ^a   Rysava R ^a   Horak P ^b   Hrncir Z ^a   Lukac J ^c   Rovensky J ^c   Vitova J ^d   Havrda, M ^a   Rychlik I ^a   Bohmova J ^e   Vlasakova V ^f   Slatinska J ^g   Zadrazil J ^b   Olejarova M ^a   Tegzova, D ^a   Tesar, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c National Institute of Rheumatology   (Slovakia)

^d University Hospital   (Czech Republic)

^e ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^f Medipont Plus   (Czech Republic)

^g INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

cyclosporine A; Lupus nephritis; systemic lupus erythematosus; treatment

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEINURIA;

CYCLOSPORINE A; LUPUS NEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT;

CELL PROLIFERATION; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY;

EID: 84890458837     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313511555     Document Type: Article

References (15)

1. Berden JH. Lupus nephritis. Kidney Int. 1997 ; 52: 538-558
2. Huong DL, Papo T, Beaufils H, et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore). 1999 ; 78: 148-166
3. Appel GB, Contreras G, Dooley MA, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009 ; 20: 1103-1112
4. Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med. 2000 ; 343: 1156-1162
5. Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med. 2004 ; 350: 971-980
6. Grootscholten C, Ligtenberg G, Hagen EC, et al. Azathioprine/ methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int. 2006 ; 70: 732-742
7. Austin HA, 3rd, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986 ; 314: 614-619
8. Boumpas DT, Austin HA, 3rd, Vaughan EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992 ; 340: 741-745
9. Gourley MF, Austin HA, 3rd, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med. 1996 ; 125: 549-557
10. Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001 ; 135: 248-257
11. Katsifis GE, Tzioufas AG. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus. 2004 ; 13: 673-678
12. Ntali S, Bertsias G, Boumpas DT. Cyclophosphamide and lupus nephritis: when, how, for how long?. Clin Rev Allergy Immunol. 2011 ; 40: 181-191
13. Zavada J, Pesickova S, Rysava R, et al. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: The Cyclofa-Lune study. Lupus. 2010 ; 19: 1281-1289
14. Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 ; 150: 604-612
15. Houssiau FA, Vasconcelos C, D'Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010 ; 69: 61-64